Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

13.99
Delayed Data
As of 4:01pm ET
 -0.74 / -5.02%
Today’s Change
13.00
Today|||52-Week Range
101.40
-3.65%
Year-to-Date
Analysts dismiss Citron's sour take on TransDigm
2:53pm / TheStreet.com - Paid Partner Content
Frontrunning: January 18
Jan 18 / Investing Channel - Paid Partner Content
A Fond Farewell
Jan 21 / GuruFocus News - Paid Partner Content
Will This Be a Genius or Foolish Move for Johnson & Johnson?
Jan 13 / MotleyFool.com - Paid Partner Content
Short-Seller Andrew Left Says Trump Should Target This Aerospace Stock
Jan 20 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News
Jan 13 / Zacks.com - Paid Partner Content
What Will Valeant Pharmaceuticals Sell Off Next?
Jan 20 / MotleyFool.com - Paid Partner Content
Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again
Jan 12 / Zacks.com - Paid Partner Content
Why TransDigm Stock Tumbled 12% Today
Jan 20 / MotleyFool.com - Paid Partner Content
Valeant Streamlines Portfolio with Skincare Brands Sale
Jan 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close14.73
Today’s open14.70
Day’s range13.88 - 14.75
Volume18,776,440
Average volume (3 months)17,385,032
Market cap$5.0B
Dividend yield--
Data as of 4:01pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-46.52%
Earnings growth (next 5 years)+9.40%
Revenue growth (last year)+26.42%
P/E ratioNM
Price/Sales3.32
Price/Book0.85

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc-0.44-0.95%
OPKOPKO Health Inc-0.12-1.39%
GRFSGrifols SA+0.07+0.41%
IONSIonis Pharmaceutical...-3.03-6.45%
Data as of 4:02pm ET, 01/23/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)$1.22
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts


Search for Jobs